Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

NCT00006047 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: Oral Etoposide
DRUG: Oral 9-Nitrocamptothecin

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]
[object Object]